18 March 2024

Join us for our securities class actions webinar

We’re delighted to announce our forthcoming webinar in which our experts will provide comprehensive insights and practical guidance on how to navigate the complexities of global securities class actions. 

Understand the nuances of securities class actions and how you can protect and assert your rights as an investor. The session is designed to be interactive, providing you with the opportunity to engage with our experts and ask questions relevant to your financial interests and challenges. 

This will take place on Wednesday 17th April at 9.30am AEST/6.30pm CST/7.30pm EST and will be an interactive webinar with leading international securities firm Grant & Eisenhofer (G&E).  

G&E has recovered over $30 billion for its clients over the past 16 years and has successfully undertaken many high-profile international cases. These include a $2.67 billion antitrust settlement with Blue Cross Blue Shield, a $1.6 billion mass tort settlement with Bayer linked to the Essure device, a $486 million securities litigation settlement with Pfizer, and achieved a number of important corporate governance reforms in seminal cases against AIG, News Corp, and Toll Brothers.  

G&E is currently serving as global counsel and evaluating numerous cases in countries throughout Europe, North and South America, Asia, and the Asia Pacific region. These include matters in Australia, Brazil, Canada, Denmark, France, Germany, Greece, Japan, the Netherlands, Portugal, and the United Kingdom. 

Olav Haazen (Principal) and Guus Warringa (Institutional Investor Relations) will discuss important developments in these markets: 

England: Are the courts becoming investor friendly? 

Germany: Many scandals and huge losses for investors. 

Brazil: Arbitration, the alternative to the court system. 

Netherlands: Is this the new Delaware? 

Japan: Deviating loss methodologies. 

This webinar will be invaluable for asset managers in any sector, and we’re looking forward to a stimulating exchange of ideas and information – do join us. 

To join the webinar, click here.

Awards and Accreditations